Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts
Siham Moatassim-Billah(Mohammed V University), Corinne Bousquet(Centre National de la Recherche Scientifique), Aurélie Perraud(Centre Hospitalier Universitaire de Limoges), Christine Jean(Centre National de la Recherche Scientifique), Youssef Bakri(Mohammed V University), Stéphanie Cassant‐Sourdy(Université Toulouse III - Paul Sabatier), Stéphane Pyronnet(Centre National de la Recherche Scientifique), Camille Duluc(Inserm), Rémi Samain(Inserm), Herbert Schmid(Novartis (Switzerland)), Yvan Martineau(Centre National de la Recherche Scientifique), Muriel Mathonnet(Inserm), Emilie Decaup(Université Toulouse III - Paul Sabatier), Janick Sèlves(Institut universitaire du cancer de Toulouse Oncopole)
Cited by 39
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284